Bessemer Group Inc. Holds Stake in PAREXEL International Corporation (PRXL)

Bessemer Group Inc. held its position in PAREXEL International Corporation (NASDAQ:PRXL) during the second quarter, Holdings Channel reports. The institutional investor owned 24,400 shares of the medical research company’s stock at the end of the second quarter. Bessemer Group Inc.’s holdings in PAREXEL International Corporation were worth $2,121,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of PRXL. Public Employees Retirement System of Ohio raised its position in PAREXEL International Corporation by 4.5% in the first quarter. Public Employees Retirement System of Ohio now owns 1,713 shares of the medical research company’s stock worth $108,000 after buying an additional 73 shares in the last quarter. Meadow Creek Investment Management LLC raised its position in PAREXEL International Corporation by 7.1% in the first quarter. Meadow Creek Investment Management LLC now owns 1,980 shares of the medical research company’s stock worth $125,000 after buying an additional 132 shares in the last quarter. Baird Financial Group Inc. raised its position in PAREXEL International Corporation by 2.3% in the first quarter. Baird Financial Group Inc. now owns 5,812 shares of the medical research company’s stock worth $367,000 after buying an additional 133 shares in the last quarter. Isthmus Partners LLC raised its position in PAREXEL International Corporation by 1.3% in the first quarter. Isthmus Partners LLC now owns 11,516 shares of the medical research company’s stock worth $727,000 after buying an additional 145 shares in the last quarter. Finally, Capstone Asset Management Co. raised its position in PAREXEL International Corporation by 3.8% in the first quarter. Capstone Asset Management Co. now owns 4,409 shares of the medical research company’s stock worth $278,000 after buying an additional 160 shares in the last quarter. Institutional investors own 93.48% of the company’s stock.

Shares of PAREXEL International Corporation (NASDAQ:PRXL) opened at 87.67 on Thursday. The firm has a 50 day moving average price of $87.30 and a 200 day moving average price of $73.74. PAREXEL International Corporation has a 52 week low of $51.16 and a 52 week high of $87.86. The company has a market capitalization of $4.45 billion, a price-to-earnings ratio of 38.54 and a beta of 0.79.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/2797874/bessemer-group-inc-holds-stake-in-parexel-international-corporation-prxl.html.

A number of brokerages recently commented on PRXL. Zacks Investment Research upgraded PAREXEL International Corporation from a “hold” rating to a “buy” rating and set a $98.00 price target on the stock in a report on Tuesday. Barclays PLC lowered PAREXEL International Corporation from an “overweighr” rating to an “equal weight” rating and set a $87.00 price target on the stock. in a report on Tuesday, June 20th. Jefferies Group LLC reiterated a “hold” rating and set a $88.10 price target on shares of PAREXEL International Corporation in a report on Wednesday, June 21st. Raymond James Financial, Inc. upgraded PAREXEL International Corporation from an “underperform” rating to a “mkt perform” rating in a report on Tuesday, June 20th. Finally, BidaskClub lowered PAREXEL International Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $75.93.

About PAREXEL International Corporation

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Want to see what other hedge funds are holding PRXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PAREXEL International Corporation (NASDAQ:PRXL).

Institutional Ownership by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)

Receive News & Ratings for PAREXEL International Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.